Novo Nordisk | NVO - 贸易债权人

金融业

DKK

DKK 76.18B

现金及等价物

DKK 38.94B

DKK 1.95B

DKK 25.71B

DKK 32.79B

DKK 118.72B

股息收益率

DKK 3.11

DKK 5.18B

DKK 31.44B

DKK 54.39K

EPS每股收益

DKK 1.02

股本和储备

DKK 26.56B

DKK 64.01B

债务利息支出

DKK 82.1M

DKK 3.43B

DKK 14.02B

DKK 157.42B

DKK 4.03B

DKK 6.5B

DKK 5.18B

普通股股本

DKK 4.44B

13.93

DKK 25.52B

DKK 12.53B

销售和管理费用

DKK 2.86B

DKK 42.85B

贸易债权人

DKK 4.46B

应收帐款人

DKK 14.27B

	贸易债权人	更改		日
ANI Pharmaceuticals	USD 69.69M		7.11M	2026-03
Aurora Cannabis	CAD 68.03M		18.68M	2025-12
Bausch Health Companies	USD 593M		7M	2026-03
Bristol-Myers Squibb	USD 4.23B		659M	2026-03
Canopy Growth	CAD 19.96M		1.83M	2025-12
Corcept Therapeutics	USD 33.31M		7.14M	2026-03
Drreddys Laboratories	INR 454.04M		854K	2025-12
Eli Lilly	USD 5.03B		350M	2026-03
GlaxoSmithKline	GBP 14.34B		1.05B	2026-03
Merck	USD 3.86B		541M	2026-03
Nektar Therapeutics	USD 10.77M		4.79M	2025-12
Novartis	USD 4.32B		134M	2026-03
Novo Nordisk	DKK 14.8B		4.96B	2026-03
Novo Nordisk	DKK 4.46B		15.12B	2025-06
Pacira	USD 14.01M		1.14M	2026-03
Perrigo	USD 434.8M		39.7M	2026-03
Phibro Animal Health	USD 129.64M		3.65M	2026-03
Prestige Brands	USD 42.95M		1.02M	2025-12
Sanofi	EUR 22.71B		219M	2026-03
Supernus Pharmaceuticals	USD 10.17M		97.63M	2026-03
Zoetis	USD 507M		20M	2026-03